Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2025 02:30 ET | Source: Yaqrit

Yaqrit’s HE candidates set for phase 3 as company shows underpinning data at EASL

Yaqrit presents phase 2a data at EASL on oral HE prevention treatment; and an improved HE patient staging tool approved for use by FDA in HE phase 3
April 28, 2025 11:27 ET | Source: Yaqrit

Yaqrit showcases clinical progress at the European Association for the Study of the Liver (EASL) Congress, May 7-10th

Yaqrit announces eight upcoming presentations at the EASL Congress showcasing progress for drugs and devices in late stage trials in advanced liver disease
October 10, 2024 06:00 ET | Source: Tradable Bits

East Asia Super League Names Tradable Bits Official Fan Engagement Partner

East Asia Super League (EASL), East Asia’s premier basketball league and entertainment experience, today announced that global leader in fan tech Tradable
June 06, 2024 11:15 ET | Source: Barinthus Biotherapeutics

Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B

Barinthus Bio presents updated data from two clinical trials in people with chronic hepatitis B at EASL Congress 2024.
June 24, 2023 05:30 ET | Source: Vir Biotechnology, Inc.

Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 as Therapies for Chronic Hepatitis B and Hepatitis D

– Data from two ongoing clinical trials in people living with chronic hepatitis B infection suggest the combination of an antiviral with an immunomodulator can achieve rapid and deep declines in...
June 07, 2023 16:00 ET | Source: INVENTIVA

Inventiva annonce cinq présentations scientifiques lors de l’EASL International Liver Congress™ 2023

Cinq présentations par poster démontrant : La corrélation entre l'amélioration de la stéatose hépatique et une forte augmentation du taux d'adiponectine, l’amélioration du profil lipidique et du...
June 07, 2023 16:00 ET | Source: INVENTIVA

Inventiva announces five scientific presentations at the EASL International Liver Congress™ 2023

Five poster presentations showing : the correlation between the improvement of hepatic steatosis and a robust increase in adiponectin levels, improvement in lipid profile and glycemic control in...
June 07, 2023 09:00 ET | Source: Sagimet Biosciences Inc.

Sagimet Biosciences to Present Interim Data from Phase 2b Trial of Denifanstat in NASH at EASL Congress 2023

SAN MATEO, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic pathways,...
June 07, 2023 02:13 ET | Source: Vir Biotechnology, Inc.

Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B and D Data Accepted for Presentation at EASL™ Congress 2023

SAN FRANCISCO, June 07, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that five abstracts highlighting new data from the Company’s broad hepatitis portfolio...
June 16, 2022 16:00 ET | Source: INVENTIVA

Inventiva to host a webcast with Key Opinion Leaders following the EASL International Liver Congress™ 2022

Update on Inventiva’s NATiV3 Phase III clinical trial evaluating lanifibranor in patients with NASH and fibrosis (stage F2/F3) non-cirrhotic by Prof. Sven FrancqueUpdate on the current NASH landscape...